Regen BioPharma, Inc. (RGBPP)
Develops cell therapies and drug compounds to treat cancer and autoimmune diseases.
$0.00-0.31%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-87.8%
The outlook
RGBPP is trading at $0.0031, well below both its 50- and 200-day moving averages and sits near the bottom of its 52-week range. Analyst coverage appears thin on this microcap biotech stock. The overall data picture leans bearish, with the price well below longer-term trend levels.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.10
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.02
Trailing P/E
—